HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Crona, N. Articles by Samsioe, G. Search for Related Content PubMed PubMed Citation Articles by Crona, N. Articles by Samsioe, G.

A double-blind cross-over study on the effects of ORG OD14 compared to oestradiol valerate and placebo on lipid and carbohydrate metabolism in oophorectomized women

ORG OD14 is a synthetic steroid which in traditional bioassays has been shown to have oestrogenic and progestogenic as well as very weak androgenic-anabolic properties. As judged from earlier studies, this steroid seems suitable for continuous treatment of climacteric deficiency symptoms. The aim of this study was to evaluate the effects induced by OD14 on lipid, lipoprotein and carbohydrate metabolism, as compared to E₂V and placebo.

Twenty-two women, oophorectomized as part of the treatment of cervical carcinoma in clinical stage IB or IIA, were given ORG OD14 2.5 mg/day, oestradiol valerate (E₂V) 2 mg/day and a placebo for 6 weeks each, in a double-blind cross-over study.

There was a marked decrease in all lipid components of HDL (high density lipoprotein), i.e. total and free cholesterol, triglycerides and phospholipids (P < 0.001), after OD14. The oral glucose tolerance test showed higher values after OD14 compared to both E₂V and placebo (P < 0.05), indicating a slightly impaired glucose tolerance. The lipid metabolic changes induced by OD14 indicate a rather strong androgenic influence in this respect.

This article has been cited by other articles:

				T. B. Clarkson, M. S. Anthony, and J. D. Wagner A Comparison of Tibolone and Conjugated Equine Estrogens Effects on Coronary Artery Atherosclerosis and Bone Density of Postmenopausal Monkeys J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5396 - 5404. [Abstract] [Full Text] [PDF]

				D. Crook Lipid predictors of coronary heart disease and tibolone users Eur. Heart J. Suppl., October 1, 2001; 3(suppl_M): M22 - M26. [Abstract] [PDF]

				N. H. Bjarnason, K. Bjarnason, J. Haarbo, H. J.T. C. Bennink, and C. Christiansen Tibolone: Influence on Markers of Cardiovascular Disease J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1752 - 1756. [Abstract] [Full Text] [PDF]

				A. Cagnacci, E. Mallus, F. Tuveri, R. Cirillo, A. M. Setteneri, and G. B. Melis Effect of Tibolone on Glucose and Lipid Metabolism in Postmenopausal Women J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 251 - 253. [Abstract] [Full Text] [PDF]